Last reviewed · How we verify
The group receiving dexmedetomidine infusion
At a glance
| Generic name | The group receiving dexmedetomidine infusion |
|---|---|
| Sponsor | Ankara Etlik City Hospital |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Effect of Lidocaine Infusion Versus Dexmedemidine Infusion on the Neurocognitive Function of Elderly Patients Undergoing Endoscopic Retrograde Cholangiopancreatography(ERCP): a Randomized, Controlled Trial. (NA)
- Opioid Free and Opioid Based Anesthesia in Elective Lumbar Spine Surgery
- Safety and Efficacy of Dexmedetomidate vs. Midazolam for Procedural Sedation During Medical Thoracoscopy (PHASE3)
- Using Lidocaine or Dexmedetomidine to Help Control Blood Pressure Spikes From a Tourniquet During Knee Surgery (PHASE2)
- The Effects of Dexmedetomidine on Postoperative Cognitive Function in Open Heart Surgery (NA)
- Dexmedetomidine for Improving Emergence Quality in Thyroid Surgery (PHASE4)
- Comparison of Anesthetic Techniques for Early Recovery After Ankle Arthroscopy (NA)
- Magnesium vs. Dexmedetomidine in TURBT Under Spinal Anesthesia (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: